Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases

被引:60
作者
Kim, JE [1 ]
Kim, BJ [1 ]
Jeong, MS [1 ]
Seo, SJ [1 ]
Kim, MN [1 ]
Hong, CK [1 ]
Ro, BI [1 ]
机构
[1] Chung Ang Univ, Med Ctr, Dept Dermatol, Coll Med, Seoul 156756, South Korea
关键词
CAP18 lipopolysaccharide-binding protein; LL-37; keratinocytes; HaCaT cell; psoriasis; dermatitis; atopic;
D O I
10.3346/jkms.2005.20.4.649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Defensins and cathelicidins (LL-37) are major antimicrobial peptides (AMPs) of the innate immune system of the human skin. In normal non-inflamed skin these peptides are negligible, but their expression can be markedly increased in inflammatory skin disease such as psoriasis. We designed this study to identify the expressions of LL-37 in normal human keratinocyte (NHK) and HaCaT cells after exposure to stimulants and to investigate difference of LL-37 expression accompanied with cell differentiation status, and come to understand difference of susceptibility to infection in atopic dermatitis and psoriasis. Expressions of LL-37 in NHKs and HaCaT cells were evaluated by using RT-PCR, Western blotting, and immunohistochemical (IHC) staining at 6, 12, and 24 hr post stimulation after exposure to Ultraviolet B irradiation and lipopolysaccharide. And expression of LL-37 in skin biopsy specimens from patients with atopic dermatitis and psoriasis was determined by immunohistochemical analysis. In time-sequential analyses of LL-37 expression revealed that LL-37 was expressed in NHKs, but not in HaCaT cells. IHC analysis confirmed the presence of abundant LL-37 in the epidermis of psoriasis. Therefore we deduced that expression of LL-37 is affected by UV irradiation, bacterial infection, and status of cell differentiation.
引用
收藏
页码:649 / 654
页数:6
相关论文
共 26 条
[11]   An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J].
Koczulla, R ;
von Degenfeld, G ;
Kupatt, C ;
Krötz, F ;
Zahler, S ;
Gloe, T ;
Issbrüicker, K ;
Unterberger, P ;
Zaiou, M ;
Lebherz, C ;
Karl, A ;
Raake, P ;
Pfosser, A ;
Boekstegers, P ;
Welsch, U ;
Hiemstra, PS ;
Vogelmeier, C ;
Gallo, RL ;
Clauss, M ;
Bals, R .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (11) :1665-1672
[12]   HUMAN CAP18 - A NOVEL ANTIMICROBIAL LIPOPOLYSACCHARIDE-BINDING PROTEIN [J].
LARRICK, JW ;
HIRATA, M ;
BALINT, RF ;
LEE, J ;
ZHONG, J ;
WRIGHT, SC .
INFECTION AND IMMUNITY, 1995, 63 (04) :1291-1297
[13]   Atopic dermatitis: New insights and opportunities for therapeutic intervention [J].
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) :860-876
[14]   Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva [J].
Murakami, M ;
Ohtake, T ;
Dorschner, RA ;
Gallo, RL .
JOURNAL OF DENTAL RESEARCH, 2002, 81 (12) :845-850
[15]   Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin [J].
Murakami, M ;
Ohtake, T ;
Dorschner, RA ;
Schittek, B ;
Garbe, C ;
Gallo, RL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) :1090-1095
[16]   Cathelicidins and innate defense against invasive bacterial infection [J].
Nizet, V ;
Gallo, RL .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (09) :670-676
[17]   Innate antimicrobial peptide protects the skin from invasive bacterial infection [J].
Nizet, V ;
Ohtake, T ;
Lauth, X ;
Trowbridge, J ;
Rudisill, J ;
Dorschner, RA ;
Pestonjamasp, V ;
Piraino, J ;
Huttner, K ;
Gallo, RL .
NATURE, 2001, 414 (6862) :454-457
[18]   Endogenous antimicrobial peptides and skin infections in atopic dermatitis [J].
Ong, PY ;
Ohtake, T ;
Brandt, C ;
Strickland, I ;
Boguniewicz, M ;
Ganz, T ;
Gallo, RL ;
Leung, DYM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (15) :1151-1160
[19]  
PARK YM, 2003, KOREAN J INVEST DERM, V10, P1
[20]   Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes [J].
Pivarcsi, A ;
Koreck, A ;
Bodai, L ;
Széll, M ;
Szeg, C ;
Belso, N ;
Kenderessy-Szabó, A ;
Bata-Csörgo, Z ;
Dobozy, A ;
Kemény, L .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 296 (03) :120-124